{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-142106","form_type":"8-K","ticker":"VIVS","cik":"0001497253","company_name":"VivoSim Labs, INC.","filed_at":"2026-04-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.367470+00:00","generated_at":"2026-05-15T07:35:30.094887+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"VivoSim prices up to $4M public offering, closes initial $3M tranche","bullets":["Initial closing raised $3M at $1.14/share; 286,557 shares + 2,345,022 pre-funded warrants sold.","Common warrants issued at 150% coverage, exercise price $1.71, expire 5 years from issuance.","Second $1M tranche contingent on stock price >$1.43 and avg daily volume >$100K.","Net proceeds ~$2.5M for working capital, R&D, and general corporate purposes.","Joseph Gunnar & Co. placement agent with 7.5% cash fee and 131,579 placement agent warrants."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-142106","json":"https://secwatch.observer/filing/0001193125-26-142106.json","markdown":"https://secwatch.observer/filing/0001193125-26-142106.md","text":"https://secwatch.observer/filing/0001193125-26-142106.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1497253/000119312526142106/0001193125-26-142106-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1497253/000119312526142106/vivs-20260331.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T07:35:30.094887+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6f1d9765c0bc736e4663ab25e3373dde81ab307d","claim":"VivoSim Labs, INC. entered into Securities Purchase Agreement with certain accredited investors (effective 2026-03-31).","evidence_excerpt":"In connection with the Offering, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) on March 31, 2026, the form of which is filed as Exhibit 10.1, and which contains customary representations and warranties and agreements of each party thereto and customary indemnification rights and oblig","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1497253/000119312526142106/0001193125-26-142106-index.htm","confidence":0.92,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Effective","value":"2026-03-31"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}